These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5556528)

  • 21. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF; Lockerbie L; Laws EA
    Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of mixtures of topical corticosteroids as a mechanism for improving total drug bioavailability: a preliminary report.
    Poulsen BJ; Chowhan ZT; Pritchard R; Katz M
    Curr Probl Dermatol; 1978; 7():107-20. PubMed ID: 752447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of the efficiency of various externally used corticosteroids].
    Horácek J; Semrádová V
    Z Hautkr; 1974 Jul; 49(13):555-8. PubMed ID: 4423320
    [No Abstract]   [Full Text] [Related]  

  • 26. The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity?
    Stoughton RB; Wullich K
    Arch Dermatol; 1989 Nov; 125(11):1509-11. PubMed ID: 2817915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical steroid preparations. The relationship between the clinical use and the formulation of the product base.
    Hirst C
    Aust Fam Physician; 1980 Nov; 9(11):816-9. PubMed ID: 7213216
    [No Abstract]   [Full Text] [Related]  

  • 28. Proprietary hydrocortisone creams. Vasoconstrictor activities and bio-availabilities of six preparations.
    Barry BW; Woodford R
    Br J Dermatol; 1976 Oct; 95(4):423-5. PubMed ID: 974028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The particle size of dexamethasone incorporated in ointments and its relation to the penetration of emulsion ointments into the horny layer of the skin in vivo].
    Kleine-Natrop HE
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(3):425-31. PubMed ID: 1024238
    [No Abstract]   [Full Text] [Related]  

  • 30. [DNA-synthesis and hyperplasia of the epidermis after stripping and application of ointments].
    Christophers E
    Arch Klin Exp Dermatol; 1968; 233(3):277-86. PubMed ID: 5729263
    [No Abstract]   [Full Text] [Related]  

  • 31. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 32. Bullous pemphigoid--management of a patient with oral and skin lesions.
    Ali TB; Zain RB; Adam BA
    Singapore Dent J; 1994 Jan; 19(1):18-21. PubMed ID: 9582679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical glucocorticoids. How they are used and misused.
    Fusaro RM; Kingsley DN
    Postgrad Med; 1986 Jan; 79(1):283-91. PubMed ID: 3941817
    [No Abstract]   [Full Text] [Related]  

  • 34. Modulation of dihydroavenanthramide D release and skin penetration by 1,2-alkanediols.
    Heuschkel S; Wohlrab J; Schmaus G; Neubert RH
    Eur J Pharm Biopharm; 2008 Sep; 70(1):239-47. PubMed ID: 18514497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reducing the dosage by new technology].
    Steinhorst M
    Hautarzt; 2001 Jan; 52(1):p following 90 (91). PubMed ID: 11220248
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW; Woodford R
    Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
    [No Abstract]   [Full Text] [Related]  

  • 37. Plethysmographic recordings of skin pulses. VI. Further measurements of the vasoconstriction produced by corticosteroids.
    Thune P
    Acta Derm Venereol; 1972; 52(4):303-7. PubMed ID: 4115885
    [No Abstract]   [Full Text] [Related]  

  • 38. Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
    Krochmal L; Wang JC; Patel B; Rodgers J
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):979-84. PubMed ID: 2808834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical corticosteroids: clinical pharmacology and therapeutic use.
    Miller JA; Munro DD
    Drugs; 1980 Feb; 19(2):119-34. PubMed ID: 7363838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The external treatment of dermatoses (author's transl)].
    Ormea F
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):637-42. PubMed ID: 4212846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.